GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$222M
AUM Growth
+$2.71M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
48
New
Increased
Reduced
Closed

Top Buys

1
+$8.27M
2
+$7.92M
3
+$7.8M
4
OCRX
Ocera Therapeutics, Inc.
OCRX
+$7.66M
5
VCEL icon
Vericel Corp
VCEL
+$6.18M

Top Sells

1
+$9.03M
2
+$6.99M
3
+$5.76M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$5.49M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$4.25M

Sector Composition

1 Healthcare 74.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$20M 8.6%
793,864
+135,880
2
$18.2M 7.82%
1,161,739
-350,364
3
$14.8M 6.34%
1,100,000
+141,400
4
$14.2M 6.1%
174,657
+67,303
5
$11.7M 5.02%
300,000
+49,900
6
$10.3M 4.43%
97,320
+77,992
7
$9.68M 4.16%
1,161,604
+13,312
8
$9.67M 4.15%
1,008,062
9
$9.24M 3.97%
600,000
-453,895
10
$9.11M 3.91%
1,859,315
+1,562,371
11
$8.2M 3.52%
264,873
-35,827
12
$7.92M 3.4%
+2,474,076
13
$7.8M 3.35%
+5,100,000
14
$7.5M 3.22%
651,325
+519,358
15
$7.11M 3.05%
259,698
+17,661
16
$6.18M 2.66%
+2,170,000
17
$6.18M 2.65%
+290,000
18
$5.92M 2.54%
607,296
+146,086
19
$5.43M 2.33%
+70,000
20
$4.79M 2.06%
815
-145
21
$4.65M 2%
1,585,500
22
$4.38M 1.88%
35
-31
23
$3.39M 1.46%
960
+296
24
$3.18M 1.37%
315,000
+11,287
25
$2.75M 1.18%
178,900
-8,600
1
2